On January 20, 2022, Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable viral production, announced a strategic partnership with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and hMSC bioprocess systems. This partnership will optimize manufacturing of extracellular vesicles (EVs) using scalable and continuous bioprocessing technologies to propel the commercialization of regenerative therapies at affordable costs. The goal is to deliver complete solutions for exosome manufacture, leveraging Univercells Technologies’ intensified and integrated platforms and RoosterBio’s hMSC bioprocess and highly engineered media systems. As part of the partnership, RoosterBio will establish an EV production process using their hMSCs on microcarriers in the scale-X™ hydro fixed-bed bioreactor which features 2.4 m² surface for cell growth.